Release of biochemical markers of damage to neuronal and glial brain tissue is associated with short and long term neuropsychological outcome after traumatic brain injury | Journal of Neurology, Neurosurgery & Psychiatry
Frontiers | Involvement of Lipids in Alzheimer's Disease Pathology and Potential Therapies
Tau Pathology Present Decades After a Single Brain Injury | The Scientist Magazine®
CSF and blood biomarkers for Parkinson's disease - The Lancet Neurology
A molecular pathology, neurobiology, biochemical, genetic and neuroimaging study of progressive apraxia of speech | Nature Communications
Frontiers | Roles of Neutrophils in Glioma and Brain Metastases
Olfactory dysfunction in COVID-19: pathology and long-term implications for brain health: Trends in Molecular Medicine
Determinants of seeding and spreading of α-synuclein pathology in the brain | Science Advances
A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity | Fluids and Barriers of the CNS | Full Text
Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer's disease | Scientific Data
Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease - eBioMedicine
Biomedicines | Free Full-Text | Revisiting Traumatic Brain Injury: From Molecular Mechanisms to Therapeutic Interventions
Transcriptomic signatures of brain regional vulnerability to Parkinson's disease | Communications Biology
Brain tumour patient forum Michael Buckland Tests related to diagnosi…
Pathology of brain tumours: the current state of diagnostic practice
Frontiers | Biomarkers in Psychiatry: Concept, Definition, Types and Relevance to the Clinical Reality
Brain tumour patient forum Michael Buckland Tests related to diagnosi…
Biological Marker - an overview | ScienceDirect Topics
Blood GFAP as an emerging biomarker in brain and spinal cord disorders | Nature Reviews Neurology
Frontiers | The Ageing Brain: Molecular and Cellular Basis of Neurodegeneration
Cureus | A Practical Approach to the Differential Diagnosis of Intracranial Tumors: Gross, Histology, and Immunoprofile-based Algorithm
Release of biochemical markers of damage to neuronal and glial brain tissue is associated with short and long term neuropsychological outcome after traumatic brain injury | Journal of Neurology, Neurosurgery & Psychiatry
Systems-based proteomics to resolve the biology of Alzheimer's disease beyond amyloid and tau | Neuropsychopharmacology
Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study | PLOS Medicine
PDF) Assessment of biomarkers in acrylamide-induced neurotoxicity and brain histopathology in rat